• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2023

    10/11/23 11:00:37 AM ET
    $ALNY
    $ANET
    $BA
    $BALL
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Communications Equipment
    Telecommunications
    Get the next $ALNY alert in real time by email

    Upgrades

    For Coherent Corp (NYSE:COHR), B. Riley Securities upgraded the previous rating of Neutral to Buy. In the fourth quarter, Coherent showed an EPS of $0.41, compared to $0.98 from the year-ago quarter. The current stock performance of Coherent shows a 52-week-high of $60.46 and a 52-week-low of $26.29. Moreover, at the end of the last trading period, the closing price was at $33.06.

    Barclays upgraded the previous rating for PPG Industries Inc (NYSE:PPG) from Equal-Weight to Overweight. For the second quarter, PPG Indus had an EPS of $2.25, compared to year-ago quarter EPS of $1.81. The stock has a 52-week-high of $152.89 and a 52-week-low of $107.46. At the end of the last trading period, PPG Indus closed at $130.28.

    According to Barclays, the prior rating for Ball Corp (NYSE:BALL) was changed from Equal-Weight to Overweight. For the second quarter, Ball had an EPS of $0.61, compared to year-ago quarter EPS of $0.82. The current stock performance of Ball shows a 52-week-high of $62.14 and a 52-week-low of $45.13. Moreover, at the end of the last trading period, the closing price was at $46.25.

    According to Barclays, the prior rating for O-I Glass Inc (NYSE:OI) was changed from Underweight to Equal-Weight. In the second quarter, O-I Glass showed an EPS of $0.88, compared to $0.73 from the year-ago quarter. At the moment, the stock has a 52-week-high of $23.57 and a 52-week-low of $14.06. O-I Glass closed at $15.73 at the end of the last trading period.

    For Iris Energy Ltd (NASDAQ:IREN), JP Morgan upgraded the previous rating of Neutral to Overweight. NoneThe stock has a 52-week-high of $8.06 and a 52-week-low of $1.02. At the end of the last trading period, Iris Energy closed at $3.27.

    Raymond James upgraded the previous rating for Take-Two Interactive Software Inc (NASDAQ:TTWO) from Market Perform to Outperform. For the first quarter, Take-Two Interactive had an EPS of $0.27, compared to year-ago quarter EPS of $0.71. At the moment, the stock has a 52-week-high of $153.84 and a 52-week-low of $90.00. Take-Two Interactive closed at $145.24 at the end of the last trading period.

    JP Morgan upgraded the previous rating for CSX Corp (NASDAQ:CSX) from Neutral to Overweight. For the second quarter, CSX had an EPS of $0.49, compared to year-ago quarter EPS of $0.50. The stock has a 52-week-high of $34.38 and a 52-week-low of $25.81. At the end of the last trading period, CSX closed at $31.54.

    Morgan Stanley upgraded the previous rating for Cava Group Inc (NYSE:CAVA) from Equal-Weight to Overweight. For the second quarter, Cava Group had an EPS of $0.21, compared to year-ago quarter EPS of $6.23. The stock has a 52-week-high of $58.10 and a 52-week-low of $29.05. At the end of the last trading period, Cava Group closed at $32.08.

    For Shoals Technologies Group Inc (NASDAQ:SHLS), Goldman Sachs upgraded the previous rating of Neutral to Buy. For the second quarter, Shoals Technologies Gr had an EPS of $0.14, compared to year-ago quarter EPS of $0.07. The current stock performance of Shoals Technologies Gr shows a 52-week-high of $32.37 and a 52-week-low of $14.81. Moreover, at the end of the last trading period, the closing price was at $16.74.

    See all analyst ratings upgrades.

    Downgrades

    According to B of A Securities, the prior rating for The Timken Co (NYSE:TKR) was changed from Neutral to Underperform. In the second quarter, Timken showed an EPS of $2.01, compared to $1.67 from the year-ago quarter. The current stock performance of Timken shows a 52-week-high of $95.08 and a 52-week-low of $60.44. Moreover, at the end of the last trading period, the closing price was at $73.97.

    For Alnylam Pharmaceuticals Inc (NASDAQ:ALNY), Oppenheimer downgraded the previous rating of Outperform to Perform. In the second quarter, Alnylam Pharmaceuticals showed an EPS of $1.62, compared to $2.03 from the year-ago quarter. The current stock performance of Alnylam Pharmaceuticals shows a 52-week-high of $242.74 and a 52-week-low of $159.47. Moreover, at the end of the last trading period, the closing price was at $169.06.

    For Thorne HealthTech Inc (NASDAQ:THRN), Evercore ISI Group downgraded the previous rating of Outperform to Neutral. For the second quarter, Thorne HealthTech had an EPS of $0.15, compared to year-ago quarter EPS of $0.05. The stock has a 52-week-high of $10.20 and a 52-week-low of $3.46. At the end of the last trading period, Thorne HealthTech closed at $10.18.

    For Silk Road Medical Inc (NASDAQ:SILK), CL King downgraded the previous rating of Buy to Neutral. For the second quarter, Silk Road Medical had an EPS of $0.35, compared to year-ago quarter EPS of $0.45. At the moment, the stock has a 52-week-high of $58.04 and a 52-week-low of $13.80. Silk Road Medical closed at $13.99 at the end of the last trading period.

    According to Deutsche Bank, the prior rating for Cboe Global Markets Inc (BATS:CBOE) was changed from Buy to Hold. Cboe Global Markets earned $1.78 in the second quarter, compared to $1.67 in the year-ago quarter. At the moment, the stock has a 52-week-high of $164.40 and a 52-week-low of $114.18. Cboe Global Markets closed at $161.55 at the end of the last trading period.

    For Olin Corp (NYSE:OLN), Barclays downgraded the previous rating of Overweight to Equal-Weight. Olin earned $1.13 in the second quarter, compared to $2.76 in the year-ago quarter. At the moment, the stock has a 52-week-high of $64.70 and a 52-week-low of $45.05. Olin closed at $48.65 at the end of the last trading period.

    JP Morgan downgraded the previous rating for EverCommerce Inc (NASDAQ:EVCM) from Overweight to Neutral. In the second quarter, EverCommerce showed an EPS of $0.00, compared to $0.07 from the year-ago quarter. The stock has a 52-week-high of $13.47 and a 52-week-low of $5.87. At the end of the last trading period, EverCommerce closed at $9.99.

    Piper Sandler downgraded the previous rating for Arista Networks Inc (NYSE:ANET) from Overweight to Neutral. For the second quarter, Arista Networks had an EPS of $1.58, compared to year-ago quarter EPS of $1.08. The stock has a 52-week-high of $198.70 and a 52-week-low of $98.72. At the end of the last trading period, Arista Networks closed at $194.73.

    For RXO Inc (NYSE:RXO), JP Morgan downgraded the previous rating of Neutral to Underweight. RXO earned $0.08 in the second quarter, compared to $0.56 in the year-ago quarter. The current stock performance of RXO shows a 52-week-high of $23.74 and a 52-week-low of $14.75. Moreover, at the end of the last trading period, the closing price was at $19.72.

    For HubSpot Inc (NYSE:HUBS), Raymond James downgraded the previous rating of Strong Buy to Outperform. For the second quarter, HubSpot had an EPS of $1.34, compared to year-ago quarter EPS of $0.44. At the moment, the stock has a 52-week-high of $581.40 and a 52-week-low of $245.85. HubSpot closed at $467.80 at the end of the last trading period.

    Baird downgraded the previous rating for Fleetcor Technologies Inc (NYSE:FLT) from Outperform to Neutral. Fleetcor Technologies earned $4.19 in the second quarter, compared to $4.17 in the year-ago quarter. The current stock performance of Fleetcor Technologies shows a 52-week-high of $278.35 and a 52-week-low of $162.98. Moreover, at the end of the last trading period, the closing price was at $261.45.

    According to Morgan Stanley, the prior rating for Portillos Inc (NASDAQ:PTLO) was changed from Overweight to Equal-Weight. For the second quarter, Portillos had an EPS of $0.12, compared to year-ago quarter EPS of $0.13. The current stock performance of Portillos shows a 52-week-high of $25.86 and a 52-week-low of $14.87. Moreover, at the end of the last trading period, the closing price was at $15.60.

    Citigroup downgraded the previous rating for Silk Road Medical Inc (NASDAQ:SILK) from Buy to Sell. In the second quarter, Silk Road Medical showed an EPS of $0.35, compared to $0.45 from the year-ago quarter. At the moment, the stock has a 52-week-high of $58.04 and a 52-week-low of $13.80. Silk Road Medical closed at $13.99 at the end of the last trading period.

    For Perimeter Solutions SA (NYSE:PRM), UBS downgraded the previous rating of Buy to Neutral. Perimeter Solutions earned $0.31 in the second quarter, compared to $0.04 in the year-ago quarter. The stock has a 52-week-high of $11.24 and a 52-week-low of $3.67. At the end of the last trading period, Perimeter Solutions closed at $3.87.

    For Silk Road Medical Inc (NASDAQ:SILK), B. Riley Securities downgraded the previous rating of Buy to Neutral. Silk Road Medical earned $0.35 in the second quarter, compared to $0.45 in the year-ago quarter. The stock has a 52-week-high of $58.04 and a 52-week-low of $13.80. At the end of the last trading period, Silk Road Medical closed at $13.99.

    According to Stifel, the prior rating for Silk Road Medical Inc (NASDAQ:SILK) was changed from Buy to Hold. In the second quarter, Silk Road Medical showed an EPS of $0.35, compared to $0.45 from the year-ago quarter. The stock has a 52-week-high of $58.04 and a 52-week-low of $13.80. At the end of the last trading period, Silk Road Medical closed at $13.99.

    For Omnicell Inc (NASDAQ:OMCL), Keybanc downgraded the previous rating of Overweight to Sector Weight. For the second quarter, Omnicell had an EPS of $0.57, compared to year-ago quarter EPS of $0.84. The current stock performance of Omnicell shows a 52-week-high of $81.66 and a 52-week-low of $42.58. Moreover, at the end of the last trading period, the closing price was at $45.81.

    UBS downgraded the previous rating for RTX Corp (NYSE:RTX) from Buy to Neutral. For the second quarter, RTX had an EPS of $1.29, compared to year-ago quarter EPS of $1.16. At the moment, the stock has a 52-week-high of $108.84 and a 52-week-low of $68.56. RTX closed at $73.35 at the end of the last trading period.

    Oppenheimer downgraded the previous rating for Texas Instruments Inc (NASDAQ:TXN) from Outperform to Perform. For the second quarter, Texas Instruments had an EPS of $1.87, compared to year-ago quarter EPS of $2.45. At the moment, the stock has a 52-week-high of $188.12 and a 52-week-low of $145.98. Texas Instruments closed at $157.66 at the end of the last trading period.

    UBS downgraded the previous rating for Morgan Stanley (NYSE:MS) from Buy to Neutral. For the second quarter, Morgan Stanley had an EPS of $1.24, compared to year-ago quarter EPS of $1.44. The current stock performance of Morgan Stanley shows a 52-week-high of $100.99 and a 52-week-low of $74.69. Moreover, at the end of the last trading period, the closing price was at $80.13.

    See all analyst ratings downgrades.

    Initiations

    For Robinhood Markets Inc (NASDAQ:HOOD), Needham initiated coverage, by setting the current rating at Hold. In the second quarter, Robinhood Markets showed an EPS of $0.03, compared to $0.34 from the year-ago quarter. The stock has a 52-week-high of $13.23 and a 52-week-low of $7.57. At the end of the last trading period, Robinhood Markets closed at $10.04.

    Janney Montgomery Scott initiated coverage on Columbia Financial Inc (NASDAQ:CLBK) with a Buy rating. For the second quarter, Columbia Financial had an EPS of $0.11, compared to year-ago quarter EPS of $0.22. The current stock performance of Columbia Financial shows a 52-week-high of $22.37 and a 52-week-low of $14.11. Moreover, at the end of the last trading period, the closing price was at $15.98.

    With an Underperform rating, Bernstein initiated coverage on EQT Corp (NYSE:EQT). The price target seems to have been set at $30.00 for EQT. In the second quarter, EQT showed an EPS of $0.17, compared to $0.83 from the year-ago quarter. The current stock performance of EQT shows a 52-week-high of $44.96 and a 52-week-low of $28.11. Moreover, at the end of the last trading period, the closing price was at $44.09.

    With a Neutral rating, B of A Securities initiated coverage on Globant SA (NYSE:GLOB). The price target seems to have been set at $202.00 for Globant. Globant earned $1.36 in the second quarter, compared to $1.22 in the year-ago quarter. At the moment, the stock has a 52-week-high of $210.00 and a 52-week-low of $135.41. Globant closed at $199.39 at the end of the last trading period.

    With an Overweight rating, Wells Fargo initiated coverage on WillScot Mobile Mini Holdings Corp (NASDAQ:WSC). The price target seems to have been set at $52.00 for WillScot Mobile Mini. For the second quarter, WillScot Mobile Mini had an EPS of $0.43, compared to year-ago quarter EPS of $0.32. At the moment, the stock has a 52-week-high of $53.46 and a 52-week-low of $37.83. WillScot Mobile Mini closed at $42.50 at the end of the last trading period.

    With an Underweight rating, JP Morgan initiated coverage on Riot Platforms Inc (NASDAQ:RIOT). The price target seems to have been set at $6.50 for Riot Platforms. In the second quarter, Riot Platforms showed an EPS of $0.17, compared to $0.50 from the year-ago quarter. At the moment, the stock has a 52-week-high of $20.65 and a 52-week-low of $3.26. Riot Platforms closed at $10.16 at the end of the last trading period.

    HC Wainwright & Co. initiated coverage on Erasca Inc (NASDAQ:ERAS) with a Buy rating. The price target for Erasca is set to $10.00. Erasca earned $0.21 in the second quarter, compared to $0.30 in the year-ago quarter. At the moment, the stock has a 52-week-high of $9.25 and a 52-week-low of $1.82. Erasca closed at $2.49 at the end of the last trading period.

    Evercore ISI Group initiated coverage on RayzeBio inc (NASDAQ:RYZB) with an Outperform rating. At the moment, the stock has a 52-week-high of $26.00 and a 52-week-low of $17.95. RayzeBio closed at $20.00 at the end of the last trading period.

    JP Morgan initiated coverage on Cleanspark Inc (NASDAQ:CLSK) with an Overweight rating. The price target for Cleanspark is set to $5.50. For the third quarter, Cleanspark had an EPS of $0.12, compared to year-ago quarter EPS of $0.39. At the moment, the stock has a 52-week-high of $7.60 and a 52-week-low of $1.74. Cleanspark closed at $3.75 at the end of the last trading period.

    JP Morgan initiated coverage on Marathon Digital Holdings Inc (NASDAQ:MARA) with an Underweight rating. The price target for Marathon Digital Holdings is set to $5.00. In the second quarter, Marathon Digital Holdings showed an EPS of $0.13, compared to $2.28 from the year-ago quarter. The stock has a 52-week-high of $19.88 and a 52-week-low of $3.12. At the end of the last trading period, Marathon Digital Holdings closed at $8.46.

    For Cipher Mining Inc (NASDAQ:CIFR), JP Morgan initiated coverage, by setting the current rating at Neutral. For the second quarter, Cipher Mining had an EPS of $0.04, compared to year-ago quarter EPS of $0.08. At the moment, the stock has a 52-week-high of $5.29 and a 52-week-low of $0.38. Cipher Mining closed at $2.59 at the end of the last trading period.

    Goldman Sachs initiated coverage on Syndax Pharmaceuticals Inc (NASDAQ:SNDX) with a Buy rating. The price target for Syndax Pharmaceuticals is set to $30.00. In the second quarter, Syndax Pharmaceuticals showed an EPS of $0.64, compared to $0.62 from the year-ago quarter. At the moment, the stock has a 52-week-high of $29.86 and a 52-week-low of $12.07. Syndax Pharmaceuticals closed at $12.65 at the end of the last trading period.

    With a Buy rating, UBS initiated coverage on Hexcel Corp (NYSE:HXL). The price target seems to have been set at $81.00 for Hexcel. In the second quarter, Hexcel showed an EPS of $0.50, compared to $0.33 from the year-ago quarter. At the moment, the stock has a 52-week-high of $79.08 and a 52-week-low of $50.25. Hexcel closed at $68.32 at the end of the last trading period.

    UBS initiated coverage on Boeing Co (NYSE:BA) with a Buy rating. The price target for Boeing is set to $275.00. Boeing earned $0.82 in the second quarter, compared to $0.37 in the year-ago quarter. At the moment, the stock has a 52-week-high of $243.10 and a 52-week-low of $124.24. Boeing closed at $193.53 at the end of the last trading period.

    With a Neutral rating, UBS initiated coverage on Spirit AeroSystems Holdings Inc (NYSE:SPR). The price target seems to have been set at $17.00 for Spirit AeroSystems Hldgs. For the second quarter, Spirit AeroSystems Hldgs had an EPS of $1.46, compared to year-ago quarter EPS of $1.21. The current stock performance of Spirit AeroSystems Hldgs shows a 52-week-high of $38.55 and a 52-week-low of $14.65. Moreover, at the end of the last trading period, the closing price was at $17.61.

    UBS initiated coverage on Howmet Aerospace Inc (NYSE:HWM) with a Neutral rating. The price target for Howmet Aerospace is set to $51.00. For the second quarter, Howmet Aerospace had an EPS of $0.44, compared to year-ago quarter EPS of $0.35. At the moment, the stock has a 52-week-high of $51.34 and a 52-week-low of $31.30. Howmet Aerospace closed at $46.46 at the end of the last trading period.

    With a Neutral rating, UBS initiated coverage on TransDigm Group Inc (NYSE:TDG). The price target seems to have been set at $950.00 for TransDigm Gr. TransDigm Gr earned $7.25 in the third quarter, compared to $4.85 in the year-ago quarter. The stock has a 52-week-high of $940.00 and a 52-week-low of $499.99. At the end of the last trading period, TransDigm Gr closed at $866.18.

    With a Neutral rating, UBS initiated coverage on Lockheed Martin Corp (NYSE:LMT). The price target seems to have been set at $470.00 for Lockheed Martin. In the second quarter, Lockheed Martin showed an EPS of $6.73, compared to $6.32 from the year-ago quarter. The stock has a 52-week-high of $508.10 and a 52-week-low of $388.26. At the end of the last trading period, Lockheed Martin closed at $435.10.

    With a Buy rating, UBS initiated coverage on Northrop Grumman Corp (NYSE:NOC). The price target seems to have been set at $555.00 for Northrop Grumman. Northrop Grumman earned $5.34 in the second quarter, compared to $6.06 in the year-ago quarter. At the moment, the stock has a 52-week-high of $556.14 and a 52-week-low of $414.56. Northrop Grumman closed at $465.12 at the end of the last trading period.

    UBS initiated coverage on Woodward Inc (NASDAQ:WWD) with a Buy rating. The price target for Woodward is set to $152.00. In the third quarter, Woodward showed an EPS of $1.37, compared to $0.64 from the year-ago quarter. The stock has a 52-week-high of $133.15 and a 52-week-low of $81.52. At the end of the last trading period, Woodward closed at $128.35.

    UBS initiated coverage on General Dynamics Corp (NYSE:GD) with a Neutral rating. The price target for General Dynamics is set to $265.00. General Dynamics earned $2.70 in the second quarter, compared to $2.75 in the year-ago quarter. The current stock performance of General Dynamics shows a 52-week-high of $256.80 and a 52-week-low of $202.35. Moreover, at the end of the last trading period, the closing price was at $236.67.

    With a Sell rating, UBS initiated coverage on Textron Inc (NYSE:TXT). The price target seems to have been set at $73.00 for Textron. For the second quarter, Textron had an EPS of $1.46, compared to year-ago quarter EPS of $1.00. The stock has a 52-week-high of $80.60 and a 52-week-low of $58.90. At the end of the last trading period, Textron closed at $79.07.

    Stephens & Co. initiated coverage on Sprout Social Inc (NASDAQ:SPT) with an Overweight rating. The price target for Sprout Social is set to $78.00. For the second quarter, Sprout Social had an EPS of $0.07, compared to year-ago quarter EPS of $0.04. The current stock performance of Sprout Social shows a 52-week-high of $74.07 and a 52-week-low of $37.00. Moreover, at the end of the last trading period, the closing price was at $50.85.

    Wedbush initiated coverage on Cava Group Inc (NYSE:CAVA) with a Neutral rating. The price target for Cava Group is set to $33.00. For the second quarter, Cava Group had an EPS of $0.21, compared to year-ago quarter EPS of $6.23. At the moment, the stock has a 52-week-high of $58.10 and a 52-week-low of $29.05. Cava Group closed at $32.08 at the end of the last trading period.

    See all analyst ratings initiations.

    Get the next $ALNY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALNY
    $ANET
    $BA
    $BALL

    CompanyDatePrice TargetRatingAnalyst
    CSX Corporation
    $CSX
    4/23/2026$30.00Equal-Weight → Underweight
    Morgan Stanley
    CSX Corporation
    $CSX
    4/23/2026$44.00Buy → Hold
    Vertical Research
    Texas Instruments Incorporated
    $TXN
    4/23/2026$320.00Neutral → Buy
    BofA Securities
    Texas Instruments Incorporated
    $TXN
    4/23/2026$250.00Underweight → Equal Weight
    Barclays
    CSX Corporation
    $CSX
    4/23/2026$40.00 → $45.00Buy
    TD Cowen
    Portillo's Inc.
    $PTLO
    4/22/2026$9.00Buy
    Roth Capital
    CAVA Group Inc.
    $CAVA
    4/22/2026$106.00Buy
    Roth Capital
    Robinhood Markets Inc.
    $HOOD
    4/21/2026$120.00 → $110.00Overweight
    KeyBanc Capital Markets
    More analyst ratings

    $ALNY
    $ANET
    $BA
    $BALL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Woodward Elects Frederico Fleury Curado to Its Board of Directors

    FORT COLLINS, Colo., April 24, 2026 (GLOBE NEWSWIRE) -- Woodward (NASDAQ:WWD), a world leader in the design and manufacture of aerospace and industrial controls, today announced the election of Frederico Fleury Curado to its Board of Directors and its Audit Committee, effective June 1, 2026. Curado brings more than four decades of leadership experience in industrial and aerospace companies. "Fred is a proven global business leader who has helped complex organizations improve performance and sharpen strategy," said Chip Blankenship, Chair and CEO of Woodward. "His deep experience across industrial, energy, and aerospace markets, along with a strong track record in governance and his global

    4/24/26 7:00:00 AM ET
    $WWD
    Industrial Machinery/Components
    Energy

    Syndax to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on April 30, 2026

    NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (NASDAQ:SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that it will report its first quarter 2026 financial results and provide a business update on Thursday, April 30, 2026. In connection with the earnings release, Syndax's management will host a conference call and live audio webcast at 4:30 p.m. ET on Thursday, April 30, 2026. The live audio webcast and accompanying slides may be accessed through the Events & Presentations page in the Investors section of the Company's website. Alternatively, the conference call may be accessed through the following: Confere

    4/24/26 7:00:00 AM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Morgan Stanley Investment Management Launches Stablecoin Reserves Portfolio

    Morgan Stanley Investment Management (MSIM) today announced the launch of the Stablecoin Reserves Portfolio (MSNXX), part of the Morgan Stanley Institutional Liquidity Funds trust. The Stablecoin Reserves Portfolio is a new government money market fund designed to align with the stablecoin reserves investment requirements of the Guiding and Establishing National Innovation for U.S. Stablecoins Act (GENIUS Act). The Fund offers payment stablecoin issuers an eligible money market fund option where they can invest their required reserves that back their outstanding payment stablecoins. "We are pleased to deliver a new investment solution to the marketplace that seeks to address the needs of

    4/23/26 4:15:00 PM ET
    $BK
    $MS
    Major Banks
    Finance
    Investment Bankers/Brokers/Service

    $ALNY
    $ANET
    $BA
    $BALL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lee Eugene I Jr bought $1,481,480 worth of shares (286,000 units at $5.18) (SEC Form 4)

    4 - Portillo's Inc. (0001871509) (Issuer)

    3/13/26 6:15:06 PM ET
    $PTLO
    Restaurants
    Consumer Discretionary

    President & CEO Angel Stephen F bought $1,006,750 worth of shares (25,000 units at $40.27), increasing direct ownership by 21% to 146,540 units (SEC Form 4)

    4 - CSX CORP (0000277948) (Issuer)

    3/6/26 4:39:52 PM ET
    $CSX
    Railroads
    Industrials

    Director Buckley Mortimer J bought $499,966 worth of shares (2,230 units at $224.20), increasing direct ownership by 101% to 4,430 units (SEC Form 4)

    4 - BOEING CO (0000012927) (Issuer)

    3/5/26 4:59:07 PM ET
    $BA
    Aerospace
    Industrials

    $ALNY
    $ANET
    $BA
    $BALL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for REVUFORJ issued to SYNDAX PHARMACEUTICALS INC

    Submission status for SYNDAX PHARMACEUTICALS INC's drug REVUFORJ (ORIG-1) with active ingredient REVUMENIB has changed to 'Approval' on 11/15/2024. Application Category: NDA, Application Number: 218944, Application Classification: Type 1 - New Molecular Entity

    11/18/24 9:22:42 AM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for GIVLAARI issued to ALNYLAM PHARMS INC

    Submission status for ALNYLAM PHARMS INC's drug GIVLAARI (SUPPL-7) with active ingredient GIVOSIRAN SODIUM has changed to 'Approval' on 04/29/2024. Application Category: NDA, Application Number: 212194, Application Classification: Labeling

    4/30/24 1:44:03 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for OXLUMO issued to ALNYLAM PHARMS INC

    Submission status for ALNYLAM PHARMS INC's drug OXLUMO (SUPPL-4) with active ingredient LUMASIRAN SODIUM has changed to 'Approval' on 09/19/2023. Application Category: NDA, Application Number: 214103, Application Classification: Labeling

    9/20/23 2:36:38 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALNY
    $ANET
    $BA
    $BALL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CSX downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded CSX from Equal-Weight to Underweight and set a new price target of $30.00

    4/23/26 7:47:34 AM ET
    $CSX
    Railroads
    Industrials

    CSX downgraded by Vertical Research with a new price target

    Vertical Research downgraded CSX from Buy to Hold and set a new price target of $44.00

    4/23/26 7:47:34 AM ET
    $CSX
    Railroads
    Industrials

    Texas Instruments upgraded by BofA Securities with a new price target

    BofA Securities upgraded Texas Instruments from Neutral to Buy and set a new price target of $320.00

    4/23/26 7:46:31 AM ET
    $TXN
    Semiconductors
    Technology

    $ALNY
    $ANET
    $BA
    $BALL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO and Chairperson Ullal Jayshree sold $75,944,314 worth of shares (428,000 units at $177.44) as part of a pre-agreed trading plan (SEC Form 4)

    4 - Arista Networks, Inc. (0001596532) (Issuer)

    4/24/26 6:30:07 PM ET
    $ANET
    Computer Communications Equipment
    Telecommunications

    Director Howley W Nicholas gifted 3,480,640 shares, decreasing direct ownership by 85% to 606,200 units (SEC Form 4)

    4 - Perimeter Solutions, Inc. (0001880319) (Issuer)

    4/24/26 5:32:54 PM ET
    $PRM
    Major Chemicals
    Industrials

    Chief Financial Officer Luther Sherri R sold $702,000 worth of shares (2,000 units at $351.00) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 70,475 units (SEC Form 4)

    4 - COHERENT CORP. (0000820318) (Issuer)

    4/24/26 5:10:33 PM ET
    $COHR
    Electronic Components
    Technology

    $ALNY
    $ANET
    $BA
    $BALL
    SEC Filings

    View All

    SEC Form DEFA14A filed by CAVA Group Inc.

    DEFA14A - CAVA GROUP, INC. (0001639438) (Filer)

    4/24/26 4:22:03 PM ET
    $CAVA
    Restaurants
    Consumer Discretionary

    SEC Form DEF 14A filed by CAVA Group Inc.

    DEF 14A - CAVA GROUP, INC. (0001639438) (Filer)

    4/24/26 4:21:24 PM ET
    $CAVA
    Restaurants
    Consumer Discretionary

    SEC Form FWP filed by Morgan Stanley

    FWP - MORGAN STANLEY (0000895421) (Subject)

    4/24/26 3:35:12 PM ET
    $MS
    Investment Bankers/Brokers/Service
    Finance

    $ALNY
    $ANET
    $BA
    $BALL
    Leadership Updates

    Live Leadership Updates

    View All

    Coherent Corp. Announces Timing of FY2026 Third Quarter Earnings Release

    SAXONBURG, Pa., April 22, 2026 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE:COHR) ("Coherent," "We," or the "Company"), a global leader in photonics, announced today that it will release its financial results for the quarter ended March 31, 2026, on Wednesday, May 6, after the New York Stock Exchange closes. The release will be followed by a live audio webcast at 4:30 p.m. ET to discuss the results. The Company invites investors to join the live audio webcast at coherent.com/company/ investor-relations/financial-webcasts. The webcast will be recorded and a replay will be available within 24 hours after the live audio webcast on the company's website. About Coherent Coherent is the global ph

    4/22/26 7:00:00 AM ET
    $COHR
    Electronic Components
    Technology

    CAVA Announces the Retirement of Karen Kochevar from the Board

    Karen Kochevar has informed the Company that she will retire from the Board upon the expiration of her current term and will not stand for re-election at the 2026 Annual Meeting. Ms. Kochevar's decision is consistent with the Board's ongoing succession planning process and reflects her intention to conclude ten years of service on the board, including service during the Company's transition from a privately held company to a publicly traded company. Ms. Kochevar has been a valued member of the Board and has made significant contributions to the Company during a period of substantial growth and development. Brett Schulman, Co-Founder and CEO, stated, "We thank Karen for her long service

    4/21/26 4:10:00 PM ET
    $CAVA
    Restaurants
    Consumer Discretionary

    Satheeshkumar Kumarasingam named president of Pratt & Whitney Canada

    Maria Della Posta announces retirementLONGUEUIL, QC, April 9, 2026 /CNW/ -- Pratt & Whitney, an RTX (NYSE:RTX) business, today announced the appointment of Satheeshkumar "Kumar" Kumarasingam as president of Pratt and Whitney Canada, effective June 1. Kumarasingam succeeds Maria Della Posta, who announced her retirement, and will report to Pratt & Whitney president Shane Eddy. "Pratt & Whitney Canada has a leadership position in all of its segments, with a portfolio of almost 75,000 engines in service and 14,000 customers worldwide," said Eddy. "Kumar has been an instrumental leader across Pratt & Whitney and brings extensive experience and a deep understanding of customers and the markets in

    4/9/26 4:15:00 PM ET
    $RTX
    Aerospace
    Industrials

    $ALNY
    $ANET
    $BA
    $BALL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Perimeter Solutions SA

    SC 13G/A - Perimeter Solutions, Inc. (0001880319) (Subject)

    11/22/24 6:42:15 PM ET
    $PRM
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by O-I Glass Inc.

    SC 13G - O-I Glass, Inc. /DE/ (0000812074) (Subject)

    11/20/24 1:29:08 PM ET
    $OI
    Containers/Packaging
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by MARA Holdings Inc.

    SC 13G/A - MARA Holdings, Inc. (0001507605) (Subject)

    11/14/24 6:13:30 PM ET
    $MARA
    EDP Services
    Technology

    $ALNY
    $ANET
    $BA
    $BALL
    Financials

    Live finance-specific insights

    View All

    Syndax to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on April 30, 2026

    NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (NASDAQ:SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that it will report its first quarter 2026 financial results and provide a business update on Thursday, April 30, 2026. In connection with the earnings release, Syndax's management will host a conference call and live audio webcast at 4:30 p.m. ET on Thursday, April 30, 2026. The live audio webcast and accompanying slides may be accessed through the Events & Presentations page in the Investors section of the Company's website. Alternatively, the conference call may be accessed through the following: Confere

    4/24/26 7:00:00 AM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    HubSpot to Announce First Quarter 2026 Financial Results on May 7, 2026

    HubSpot, the agentic customer platform for scaling businesses, announced today that it will report its first quarter 2026 financial results after the U.S. financial markets close on Thursday, May 7, 2026. In conjunction with this report, HubSpot will host a conference call at 4:30 p.m. Eastern Time (ET) on the same day to discuss the company's first quarter 2026 financial results and its business operations and outlook. HubSpot First Quarter 2026 Financial Results When: Thursday, May 7, 2026 Time: 4:30 p.m. ET Conference Call Registration: Dial-in Link Webcast: Webcast Link To participate via telephone, please register in advance. Upon registration, participants will receive a confirma

    4/23/26 4:05:00 PM ET
    $HUBS
    Computer Software: Prepackaged Software
    Technology

    IREN to Release Q3 FY26 Results on May 7, 2026

    NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ:IREN) ("IREN") today announced that it will release its financial results for the three months ended March 31, 2026, on Thursday, May 7, 2026 and host a conference call beginning at 5:00 p.m. Eastern Time. The webcast will be recorded, and the replay will be accessible shortly after the event at https://iren.com/investor/events-and-presentations Webcast and Conference Call DetailsTime & Date:5:00 p.m. Eastern Time, Thursday, May 7, 2026 ParticipantRegistration Link Live WebcastUse this link Phone Dial-In with Live Q&AUse this link    Participants joining the conference call via the phone dial-in option will receive their di

    4/23/26 4:00:43 PM ET
    $IREN
    EDP Services
    Technology